The Zhitong Finance App learned that Keji Pharmaceutical-B (02171.HK) rose more than 4% after the results. As of press release, it had risen 4.08% to HK$15.31, with a turnover of HK$12.5726 million.

The Zhitong Finance App learned that Keji Pharmaceutical-B (02171.HK) rose more than 4% after the results. As of press release, it had risen 4.08% to HK$15.31, with a turnover of HK$12.5726 million.